'We're ahead of the pack' in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus
Jim Cramer sits down with Yuval Cohen, the CEO of a company that is creating treatments derived from manmade cannabinoids for rare diseases like cystic fibrosis.
from Latest Video https://ift.tt/2NrlSG5
from Latest Video https://ift.tt/2NrlSG5
0 Response to "'We're ahead of the pack' in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus"
Post a Comment